Skip to main content

PTSD - Post Traumatic Stress Disorder

0
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Combined Therapeutics
1 program
EMDRN/A1 trial
Active Trials
NCT06957210Active Not Recruiting130Est. Dec 2025
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Low plant diversity beverageN/A1 trial
Active Trials
NCT07107269Recruiting40Est. Jul 2026
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Narrative Exposure TherapyN/A1 trial
Active Trials
NCT07175025Recruiting106Est. Jul 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
Human BioSciencesNarrative Exposure Therapy
Colorado TherapeuticsLow plant diversity beverage
Combined TherapeuticsEMDR

Clinical Trials (3)

Total enrollment: 276 patients across 3 trials

NCT07175025Human BioSciencesNarrative Exposure Therapy

The New Empowerment After eXposure to Trauma (NEXT) Study

Start: Sep 2025Est. completion: Jul 2028106 patients
N/ARecruiting
NCT07107269Colorado TherapeuticsLow plant diversity beverage

Diet and Microbiome Interactions: Application in Posttraumatic Stress Disorder in Adults Consuming Vegetable Drinks

Start: Jun 2025Est. completion: Jul 202640 patients
N/ARecruiting
NCT06957210Combined TherapeuticsEMDR

Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder

Start: May 2025Est. completion: Dec 2025130 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 276 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.